首页> 外文OA文献 >Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis.
【2h】

Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis.

机译:SCH39304和氟康唑在弥散性球孢子菌病小鼠模型中的功效。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The efficacies of SCH39304 (SCH) and fluconazole (FLU) were tested in a murine model of coccidioidomycosis. CD-1 mice were infected with Coccidioides immitis and dosed with SCH at 2, 10, 25, or 50 mg/kg per day or FLU at 10 or 100 mg/kg per day. Survival was enhanced (P less than 0.001) by both drugs at all doses. Residual burdens of C. immitis in the organs of mice treated with SCH at 25 or 50 mg/kg per day were lower than in mice treated with FLU at 100 mg/kg per day (P less than 0.001). These results indicate that SCH is an effective therapy for coccidioidomycosis and is superior to FLU in this comparison.
机译:SCH39304(SCH)和氟康唑(FLU)的功效在球孢子菌病小鼠模型中进行了测试。 CD-1小鼠感染了球虫球菌性炎,并以每天2、10、25或50 mg / kg的SCH剂量或每天10或100 mg / kg的FLU给药。两种药物在所有剂量下均提高了生存率(P小于0.001)。每天用25或50 mg / kg的SCH治疗的小鼠器官中的衣原体感染的残余负担要低于每天用100 mg / kg的FLU治疗的小鼠的残留(P小于0.001)。这些结果表明,SCH是一种球虫病的有效疗法,并且在此比较中优于FLU。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号